Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline ntaylor Mon, 05/13/2024 - 07:11

Takeda pays AC Immune $100M upfront for Alzheimer's drug as phase 2 readout nears jwaldron Mon, 05/13/2024 - 05:52

J&J's Megadyne division pulls pediatric electrosurgery pad from market following patient burn recall chale Fri, 05/10/2024 - 14:11

First Neuralink patient sees some implanted electrodes lose connection to brain chale Fri, 05/10/2024 - 12:40

How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen aarmstrong Fri, 05/10/2024 - 10:11

FDA delays decision on Moderna's RSV shot until the end of May mbayer Fri, 05/10/2024 - 10:12